Dachaigh › Easbhaidh Alpha-1 Antitrypsin › Arizona
Sgrùdaidhean clionaigeach Easbhaidh Alpha-1 Antitrypsin ann an Arizona
Tha 3 sgrùdaidhean airson Easbhaidh Alpha-1 Antitrypsin a’ lorg phàirtichean aig làraichean ann an Arizona.
Bailtean ann an Arizona
Teacsa sgrùdaidh oifigeil (Beurla)
A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- GC2501 Study Site 102, Phoenix
- GC2501 Study Site 107, Scottsdale
A’ fastadhÌre 3
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 11 Lùna 2026 · NCT07555483Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein
- St. Joseph's Hospital and Medical Center, Phoenix
- Mayo Clinic, Phoenix
A’ fastadhÌre 3
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 13 Cèit 2026 · NCT05677971Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alpha-1 Antitrypsin Liver Disease With Mild Liver Scarring (Fibrosis)
- St Joseph's Hospital and Medical Center, Phoenix
- Mayo Clinic - PPDS, Phoenix
- University of Arizona Thomas D. Boyer Liver Institute, Tucson
A’ fastadhÌre 3
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 5 Màrt 2026 · NCT06165341Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.